0000899243-21-013526.txt : 20210325 0000899243-21-013526.hdr.sgml : 20210325 20210325183016 ACCESSION NUMBER: 0000899243-21-013526 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201204 FILED AS OF DATE: 20210325 DATE AS OF CHANGE: 20210325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Skovronsky Daniel CENTRAL INDEX KEY: 0001741474 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 21773925 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-12-04 2020-12-07 0 0000899923 MYRIAD GENETICS INC MYGN 0001741474 Skovronsky Daniel 320 WAKARA WAY SALT LAKE CITY UT 84108 1 0 0 0 Common Stock 25041 D This filing is deemed to amend the Form 4, which was filed on December 7, 2020, in error, on behalf of Mr. Skovronsky, showing a grant of 15,889 restricted stock units on December 4, 2020, to reflect that Mr. Skovronsky did not receive such grant of restricted stock units. By: Nathan A. Smith For: Daniel M. Skovronsky 2021-03-25